reverseengineer writes "The US Food and Drug Administration has given its first first approval for a therapeutic cancer vaccine. In a clinical trial 'involving 512 men, those who got Provenge (sipuleucel-T) had a median survival of 25.8 months after treatment, while those who got a placebo lived a median of 21.7 months. After three years, 32 percent of those who got Provenge were alive, compared with 23 percent of those who got the placebo. ... "The big story here is that this is the first proof of principle and proof that immunotherapy works in general in cancer, which I think is a huge observation," said Dr. Philip Kantoff, chief of solid tumor oncology at the Dana-Farber Cancer Institute in Boston and the lead investigator in Dendreon's largest clinical trial for the drug. "I think this is a very big thing and will lead to a lot more enthusiasm for the approach."'"

Homncruse sends in news of Bill Gates's new adventure, adding "I was working just one or two floors under this new office when it was all coming together. I even unknowingly shared an elevator with him at one time on his way up to the office." The article notes that the name "bgC3" derives from Bill Gates, catalyst, and the "third thing," neither Microsoft or the Bill & Melinda Gates Foundation. "Just months after his Microsoft farewell, Bill Gates is quietly creating a new company — complete with high-tech office space, a cryptic name and even its own trademark. Public documents describe the new Gates entity — bgC3 LLC — as a 'think tank.' It's housed within a Kirkland office that the Microsoft co-founder established on his own after leaving his day-to-day executive role at the company this summer ... However, bgC3 will also oversee Gates' personal pursuit of breakthrough ideas in science and technology. [An] insider said the goal isn't necessarily to create new companies, although ideas could be passed along to Microsoft, the Bill & Melinda Gates Foundation — or others — as it makes sense ..."